Pediatric cystic fibrosis: Evaluating costs and genetic testing

Journal of Pediatric Health Care

Volumn 18, Issue 1, 2004, Pages 30-34

  Balinsky, Warren ^a   Zhu, Carolyn W ^a  

^a NEW SCHOOL FOR SOCIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; CYSTIC FIBROSIS; EVALUATION; FATALITY; GENETIC DISORDER; GENETIC PROCEDURES; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; LABORATORY TEST; PEDIATRICS; PRACTICE GUIDELINE; PREVALENCE; PROPHYLAXIS; STANDARDIZATION; UNITED STATES;

EID: 0346337196     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5245(03)00110-X     Document Type: Article

References (32)

1. American College of Obstetricians and Gynecologists (ACOG) (2003). ACOG cystic fibrosis recommendations. Retrieved January 8, 2003, from http://www.ama-assn.org/ama/pub/category/6299.html .
2. Bombieri C., Pignatti P.F. Cystic fibrosis mutation testing in Italy. Genetic Testing. 5:2001;229-233.
3. Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development-proceedings of a 1997 workshop. MMWR. 46:1997;1-22.
4. Ciske D., Haavisto A., Laxova A., Zeng L., Rock M., Farrell P.M. Genetic counseling and neonatal screening for cystic fibrosis: An assessment of the communication process. Pediatrics. 107:2001;699-705.
5. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2001 Annual Data Report. 2002;Author, Bethesda, MD.
6. Cystic Fibrosis Foundation. (2003). About cystic fibrosis: What is CF. Retrieved April 8, 2003, from http://www.cff.org/about_cf.
7. Dudding T., Wilcken B., Burgess B., Turner G. Neonatal screening for cystic fibrosis (letter). Lancet. 356:2000;1930.
8. Farrell P.M., Kosorok M.R., Rock M.J., Laxova A., Zeng L., Lai H., et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics. 107:2001;1-13.
9. Fink L., Collins F. The Human Genome Project. Journal of the American Medical Women's Association. 52:1997;4-8.
10. Gander O. Prevalence and incidence of secondary and other types of diabetes. In National Diabetes Data Group, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. Diabetes In America. 1995;. (2nd ed., NIH publication No. 95-1468).
11. Garber A.M., Fenerty J.P. Costs and benefits of prenatal screening for cystic fibrosis. Medical Care. 29:1991;473-489.
12. Grody W., Cutting G., Klinger K., Richards C., Watson M., Desnick R. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetics in Medicine. 3:2001;149-154.
13. Grosskopf C., Farriaux J.P., Vidailhet M., Briard M.L., Travert G., Belot V., et al. The French national screening program for CF. Journal of Cystic Fibrosis. 1:(Suppl. 1):2002;S1-S188.
14. Halliburton C., Mannino D., Olney R. Cystic fibrosis deaths in the United States from 1979 to 1991. Archives of Pediatric & Adolescent Medicine. 150:1996;1181-1185.
15. Ireys H., Anderson G., Shaffer T., Neff J. Expenditures for care of children with chronic illnesses enrolled in the Washington state Medicaid program, fiscal year 1993. Pediatrics. 100:1997;197-204.
16. Lieu T., Kay G., Farmer G., Shay G. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics. 106:1999;72e-76e.
17. Liptak G., Burns C., Philip W., McAnarney E. Effects of providing comprehensive ambulatory services to children with chronic conditions. Archives of Pediatric & Adolescent Medicine. 152:1998;1003-1008.
18. Mann D. (1998). Study: 18% of US children suffer chronic conditions. Medical Tribune Family Physician Ed, 34. Retrieved Dec 20, 2000 from http://www.medscape.com/Jobson/MedTrib/familyphys/public/journal.FP.html.
19. Melgares P. Research at K-State uncovers potential cystic fibrosis treatment. 1999, March 11;1 K-State Research & Extension News.
20. Mennuti M., Thomson E., Press N. Screening for cystic fibrosis carrier state. Obstetrics and Gynecology. 93:1999;456-461.
21. National Institutes of Health. (1990) Workshop on population screening for the cystic fibrosis gene. Retrieved December 20, 2000, from http://odp.od.nih.gov.
22. National Institutes of Health. National Institutes of Health consensus development conference statement: Genetic testing for cystic fibrosis. Archives of Internal Medicine. 159:1999;1529-1539.
23. Rosenstein B.J., Zeitlin P.L. Cystic fibrosis. Lancet. 351:1998;277-282.
24. Rowley P., Loader S., Kaplan R. Prenatal screening for cystic fibrosis carrier: An economic evaluation. American Journal of Human Genetics. 63:1998;1160-1174.
25. Save Babies Through Screening. (2003). Screening information: What does your state screen for? Retrieved February 26, 2003, from http://savebabies.org/ screeninginformation.htm.
26. Scotet V., de Braekeleer M., Roussey M., Rault G., Parent P., Dagorne M., et al. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis. Lancet. 356:2000;789-794.
27. Silber J., Gleeson S., Zhao H. The influence of chronic disease on resource utilization in common acute pediatric conditions. Archives of Pediatric & Adolescent Medicine. 153:1999;169-180.
28. U.S. Department of Health and Human Services. The burden of chronic diseases and their risk factors: National and state perspectives 2002. 2002;Centers for Disease Control and Prevention, Atlanta.
29. Waters D.L., Wilcken B., Irwig L., Van Asperen P., Mellis C., Simpson J.M., et al. Clinical outcomes of newborn screening for cystic fibrosis. Archives of Disease in Childhood Fetal & Neonatal Education. 80:1999;F1-F7.
30. Welsh M.J., Smith A.E. Cystic fibrosis: The genetic defects underlying this lethal disease have now been shown to eliminate or hobble a critical channel through which a constituent of salt enters and leaves cells. Scientific American. 273:1995;52-59.
31. Wesley A.W., Smith P.A., Elliott R.B. Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen. Australian Pediatric Journal. 25:1989;151-155.
32. Young S.S., Kharrazi M., Pearl M., Cunningham G. Cystic fibrosis screening in newborns: Results from existing programs. Current Opinion in Pulmonary Medicine. 7:2001;427-433.